Stock VBIV VBI VACCINES INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. VBI Vaccines Inc.

Equities

VBIV

CA91822J2020

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-10 pm EDT 		5-day change 1st Jan Change
0.585 USD -1.91% Intraday chart for VBI Vaccines Inc. -4.10% -0.43%
May. 29 VBI Vaccines Inc. Announces New Tumor Response Data from Ongoing Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma Patients CI
May. 22 VBI Vaccines Inc. Announces Poster Presentation at 2024 ASCO Annual Meeting Highlighting New Interim Phase 2b Data from VBI-1901 in Recurrent Glioblastoma Patients CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Raymond James Cuts Price Target on VBI Vaccines to $6 From $60, Maintains Outperform Rating
MT
Raymond James Adjusts VBI Vaccines Price Target to $6 From $9, Maintains Strong Buy Rating
MT
Jefferies Analyst Starts VBI Vaccines at Buy, Adjusts Price Target to $6 From $7
MT
VBI VACCINES : Jefferies Starts VBI Vaccines at Buy With $7 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VBIV Stock
  4. News VBI Vaccines Inc.
  5. Analyst Reco.